Treatment of progressive forms of multiple sclerosis with laquinimod

3-5. (canceled)

7-10. (canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

A pharmaceutical composition comprising an effective amount of laquinimod for treating a progressive form of multiple sclerosis.

A package comprising:

• a. a pharmaceutical composition comprising an amount of laquinimod;
• and
• b. instruction for use of the pharmaceutical composition to treat a subject afflicted with a progressive form of multiple sclerosis.

The package of claim 35 for use as a therapeutic package for dispensing to, or for use in dispensing to, a subject afflicted with a progressive form of multiple sclerosis, which comprises:

• a. one or more unit doses, each such unit dose comprising an amount of laquinimod thereof, wherein the amount of said laquinimod in said unit dose is effective, upon administration to said subject, to treat the subject, and
• b. a finished pharmaceutical container therefor, said container containing said unit dose or unit doses, said container further containing or comprising labeling directing the use of said package in the treatment of said subject.